| Product Code: ETC7752021 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan mRNA Therapeutics Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Japan mRNA Therapeutics Market - Industry Life Cycle |
3.4 Japan mRNA Therapeutics Market - Porter's Five Forces |
3.5 Japan mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Japan mRNA Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Japan |
4.2.2 Growing investments in research and development of mRNA therapeutics |
4.2.3 Favorable regulatory environment supporting the development and adoption of mRNA therapeutics |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA therapeutics development and production |
4.3.2 Limited awareness and acceptance of mRNA therapeutics among healthcare providers and patients in Japan |
5 Japan mRNA Therapeutics Market Trends |
6 Japan mRNA Therapeutics Market, By Types |
6.1 Japan mRNA Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F |
6.1.4 Japan mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F |
6.2 Japan mRNA Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Japan mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Japan mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F |
6.2.5 Japan mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.2.6 Japan mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan mRNA Therapeutics Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Japan mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Japan mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.4 Japan mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan mRNA Therapeutics Market Import-Export Trade Statistics |
7.1 Japan mRNA Therapeutics Market Export to Major Countries |
7.2 Japan mRNA Therapeutics Market Imports from Major Countries |
8 Japan mRNA Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials involving mRNA therapeutics in Japan |
8.2 Percentage of healthcare providers trained in administering mRNA therapeutics |
8.3 Research and development expenditure dedicated to mRNA therapeutics in Japan |
9 Japan mRNA Therapeutics Market - Opportunity Assessment |
9.1 Japan mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Japan mRNA Therapeutics Market - Competitive Landscape |
10.1 Japan mRNA Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Japan mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |